| |
|
|
|
Intec Pharma Ltd  
|
|
4.13 -0.21 (-0.05%) |
01-15 16:00 |
|
Open: |
4.3 |
Pre close: |
4.34 |
Target:
|
5.11 
|
|
High: |
4.4998 |
Low: |
4.01 |
Resistance:
|
4.37
5.07
|
|
Volume: |
581,691 |
Market Cap: |
16M |
Support:
|
3.25
2.70
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
4.22
 |
MACD |
MACD(12,26):
|
0.12 |
|
MA(20): |
3.93 |
Signal(12,26,9): |
0.08 |
|
MA(100): |
4.31 |
Stochastic Oscillator |
%K(14,3):
|
63.87 |
|
MA(250): |
5.37 |
%D(3): |
62.44 |
|
Average Volume(K) |
3-Month: |
117743
|
52-Week |
High:
|
15.82 |
|
10-Days: |
119639 |
Low: |
2.20 |
|
RSI |
RSI(14):
|
53.79 |
Change(%): |
-63.3 |
|
Financials, Statistics and Valuation |
|
EPS |
-6.106 |
Return on Equity (ttm) |
-96.2 |
Shares Out. (M) |
3.95 |
|
EPS Est. Current Year |
-1.670 |
Return on Assets (ttm) |
-28.3 |
Shares Float (M) |
3.51 |
|
EPS Est. Next Year |
-1.250 |
PEG Ratio |
0.00 |
% Held by Insiders |
8.74 |
|
EPS Est. Next Quarter |
-0.700 |
Qtrly Rev. Growth |
0.0 |
% Held by Institutions |
21.82 |
|
Forward EPS |
-1.410 |
Gross Profit (p.s.) |
0.000 |
Shares Short (K) |
330 |
|
Book Value (p.s.) |
4.580 |
EBITDA (p.s.) |
-2.853 |
P/E |
-0.68 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
0.90 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-13.99 |
P/S |
0.00 |
|
Operating Margin |
0.00 |
Levered Free Cash Flow
(M) |
-10.21 |
P/CF |
-1.17 |
|
|
|
|
|
|
